A naukri.com initiative
Unite
1w
137
Image Credit: Unite
Steve Herne, CEO at Unlearn – Interview Series
- Steve Herne is the CEO at Unlearn, a company that develops AI technologies for clinical development and precision medicine. The company's focus is on digital twins, powered by its Unlearn Platform, which enable it to build virtual patient models and streamline clinical development. Herne, a former CCO, says his focus now is on aligning the company's strategic goals, vision and mission, as well as building a commercially driven business model. Herne is challenging his team to understand the voice of customers, so they can address trial and error in medicine more effectively.
- Unlearn's goal is to reduce error and decrease the number of trial participants. The company has already integrated digital twin technology into clinical trials, identitying some potential advantages, including a reduced timeline compared to the traditional trial process. Herne believes that digital twin technology has the potential to enhance every clinical trial, and that every pharmaceutical company will adopt it in protocols over the next decade.
- Herne is focused on strategic growth for the company, fosterin a culture of innovation while maintaining commercial viability of the AI solutions being developed. He wants to see clinicians viewing Unlearn as a partner of choice for creating digital twins in their clinical trials.
Read Full Article
8 Likes
For uninterrupted reading, download the app